Oral cholesteryl ester transfer protein (CETP) inhibitors: A potential new approach for treating coronary artery disease

被引:114
作者
Sikorski, JA [1 ]
机构
[1] AtheroGen Inc, Discovery Med Chem, Alpharetta, GA 30004 USA
关键词
D O I
10.1021/jm058224l
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 22
页数:22
相关论文
共 210 条
[51]  
CREW MD, 2003, Patent No. 2003000292
[52]  
Curatolo WJ., 2003, Patent No. [2003063868-A1, 2003063868]
[53]  
CURATOLO WJ, 2003, Patent No. 2003063832
[54]  
CURATOLO WJ, 2002, Patent No. 2002011710
[55]   A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly [J].
Curb, JD ;
Abbott, RD ;
Rodriguez, BL ;
Masaki, K ;
Chen, R ;
Sharp, DS ;
Tall, AR .
JOURNAL OF LIPID RESEARCH, 2004, 45 (05) :948-953
[56]  
Damon D.B., 2002, WO, Patent No. 2002088069
[57]  
Damon D. B., 2004, U.S. Patent, Patent No. [6,689,897, 6689897]
[58]  
DAMON DB, 2002, Patent No. 2002088085
[59]   A review of CETP and its relation to atherosclerosis [J].
de Grooth, GJ ;
Klerkx, AHEM ;
Stroes, ESG ;
Stalenhoef, AFH ;
Kastelein, JJP ;
Kuivenhoven, JA .
JOURNAL OF LIPID RESEARCH, 2004, 45 (11) :1967-1974
[60]   The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia [J].
de Grooth, GJ ;
Smilde, TJ ;
van Wissen, S ;
Klerkx, AHEM ;
Zwinderman, AH ;
Fruchart, JC ;
Kastelein, JJP ;
Stalenhoef, AFH ;
Kuivenhoven, JA .
ATHEROSCLEROSIS, 2004, 173 (02) :261-267